| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 29.71▼ | 29.61▲ | 29.60▲ | 29.72▼ | 28.49▲ |
| MA10 | 29.69▼ | 29.57▲ | 29.51▲ | 29.31▲ | 27.04▲ |
| MA20 | 29.64▲ | 29.48▲ | 29.40▲ | 28.32▲ | 24.37▲ |
| MA50 | 29.60▲ | 29.63▲ | 29.33▲ | 26.02▲ | 23.96▲ |
| MA100 | 29.49▲ | 29.27▲ | 29.17▲ | 23.91▲ | 21.54▲ |
| MA200 | 29.37▲ | 28.92▲ | 27.36▲ | 24.20▲ | 21.21▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.031▲ | 0.024▲ | -0.017▼ | 0.732▲ |
| RSI | 51.790▲ | 57.561▲ | 55.020▲ | 63.425▲ | 68.419▲ |
| STOCH | 59.436 | 79.623 | 84.554▲ | 63.089 | 80.738▲ |
| WILL %R | -60.000 | -19.200▲ | -14.907▲ | -41.456 | -12.831▲ |
| CCI | 2.476 | 136.352▲ | 135.074▲ | 51.434 | 120.047▲ |
| ▼ MACD | $ACAD MACD(12,26,9) Crossed Below Signal Line | Set Alert |
|
Monday, August 24, 2026 12:01 AM
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/08/26 | 29.28 | 29.77 | 29.145 | 29.65 | 866,874 |
| 21/08/26 | 29.08 | 29.615 | 28.80 | 29.50 | 1,067,488 |
| 20/08/26 | 30.00 | 30.00 | 28.95 | 29.04 | 1,318,667 |
| 19/08/26 | 30.66 | 30.96 | 30.07 | 30.21 | 2,221,998 |
| 18/08/26 | 29.14 | 30.25 | 29.05 | 30.18 | 2,020,549 |
| 17/08/26 | 28.63 | 29.03 | 28.21 | 29.01 | 1,071,255 |
| 14/08/26 | 28.26 | 28.425 | 27.9004 | 28.24 | 1,032,925 |
| 13/08/26 | 29.75 | 29.75 | 28.36 | 28.38 | 1,414,698 |
| 12/08/26 | 29.18 | 29.84 | 28.83 | 29.45 | 1,409,738 |
| 11/08/26 | 29.58 | 29.76 | 29.095 | 29.41 | 1,328,920 |
|
|
||||
|
|
||||
|
|